Pretty much agree with you Dolcevita.
MSB's sp was well supported with ASX200 entry plus on the back of the The TEVA/CEPH deal - there validation of solely speak volumes about MSB's credibility.
TEVA (wiil be circa 50bn Pharma post CEPH takevoer 3rd Qrt 2011) is receiving alot of postive press in the US
http://www.fool.com/investing/international/2011/06/01/why-tevas-earnings-are-outstanding.aspx
Nice to have a partner with Strong earnings and cash (+$3bn) on Sales of +$16bn
The market is funny at the moment but Patience will prevail.
The above is IMO only and DYOR before making any decisions.
Cheers
Pretty much agree with you Dolcevita.MSB's sp was well supported...
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
-0.210(11.8%) |
Mkt cap ! $1.792B | |||
| Open | High | Low | Value | Volume |
| $1.72 | $1.74 | $1.52 | $15.63M | 9.716M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 5127 | $1.57 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 39613 | 3 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |